These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5720683)

  • 1. Participation of beta-adrenergic receptors in the hypotensive effect of 1-(5-methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl)-piperazinyl]-1-propanone hydrochloride.
    Grewal RS; Kaul CL
    Indian J Exp Biol; 1968 Oct; 6(4):248-50. PubMed ID: 5720683
    [No Abstract]   [Full Text] [Related]  

  • 2. 1-(5-Methyl-1-phenyl-4-pyrazolyl)-3-[4-(o-tolyl) -piperazinyl]-1-propanone, a new synthetic antihypertensive agent.
    Arya VP; Grewal RS; David J; Kaul CL
    Experientia; 1967 Jul; 23(7):514-5. PubMed ID: 6057728
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the new hypotensive drug ST 155.
    Bentley GA; Li DM
    Eur J Pharmacol; 1968 Sep; 4(2):124-34. PubMed ID: 5723995
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation and abolition of the increase in plasma renin activity seen after hypotensive drugs in rats.
    Meyer DK; Peskar B; Tauchmann U; Hertting G
    Eur J Pharmacol; 1971; 16(3):278-82. PubMed ID: 5132553
    [No Abstract]   [Full Text] [Related]  

  • 5. [The mechanism of action of an antihypertensive drug DL(methylene-dioxy-3-4) phenyl-2 hydroxy-2-acetamidine chlorhydrate or LL-1418].
    Duteil J; Boutet G; Duval N; Assous E
    Therapie; 1969; 24(6):1103-13. PubMed ID: 4391608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Influencing of the vasomotor system of the extremities by beta receptors].
    Westermnann KW; Langbehn AF; Richter-von Arnauld HP; Johannes E
    Verh Dtsch Ges Inn Med; 1972; 78():1542-4. PubMed ID: 4665604
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An analysis of the antihypertensive properties of 3-nitropropionic acid, a compound from plants in the genus Astragalus].
    Castillo C; Valencia I; Reyes G; Hong E
    Arch Inst Cardiol Mex; 1993; 63(1):11-6. PubMed ID: 8466361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological studies of 2-methyl-3(2-phenyl-3-methyl-tetrahydrooxazino)-propiophenone hydrochloride and 1-phenoxycarboxy-1-phenyl-2-methyl-3(2-phenyl-3-methyl-tetrahydrooxazino)-propane hydrochloride compounds].
    Ilarionov I; Todorova P
    Eksp Med Morfol; 1980; 19(1):41-6. PubMed ID: 6104591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and synergistic interactions of 3,5,3'-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes.
    Segal J; Ingbar SH
    J Clin Invest; 1980 May; 65(5):958-66. PubMed ID: 7364946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol as an antihypertensive agent.
    Prichard BN
    Am Heart J; 1970 Jan; 79(1):128-33. PubMed ID: 4391325
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steric aspects of adrenergic drugs. VI. Beta adrenergic effects of ephedrine isomers.
    Tye A; Baldesberger R; LaPidus JB; Patil PN
    J Pharmacol Exp Ther; 1967 Aug; 157(2):356-62. PubMed ID: 6039827
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanism of action of ST 155 on the blood-pressure in rats.
    Kündig H; Monnier H; Levin NW; Charlton RW
    Arzneimittelforschung; 1967 Nov; 17(11):1440-4. PubMed ID: 5632165
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of beta adrenergic receptor agonists and blockaders on the action of bradykinin].
    Shvarts GIa
    Biull Eksp Biol Med; 1981 Nov; 92(11):575-6. PubMed ID: 6119126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo interaction of AR-L 115BS (Vardax) with the adrenergic nervous system.
    Petein M; Pierpont GL; Francis GS; Cohn JN; From AH
    J Cardiovasc Pharmacol; 1984; 6(6):1020-6. PubMed ID: 6084757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor responses in rats "intoxicated" with doxorubicin.
    Filippelli W; Russo S; Marrazzo R; Marmo M; Rossi F
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):73-80. PubMed ID: 8042011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mirtazapine on the hypotensive activity of enalapril and propranolol in spontaneously hypertensive rats.
    Andrzejczak D; Kocon K; Zieba R
    Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):450-4. PubMed ID: 18699796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E
    Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-adrenergic receptors and paradoxical sleep in the rat].
    Lanfumey L; Adrien J
    C R Seances Acad Sci III; 1981 Mar; 292(9):645-7. PubMed ID: 6263513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.